|
34. PRE-ECLAMPSIA
Pre-eclampsia is hypertension (greater than
140/90 mmHg), proteinuria (greater than 0.3 g/l/day) and oedema occurring after
20 weeks of pregnancy and usually resolving within 48 hours of delivery. It
occurs in 1 to 4% of pregnancies. There is a greater risk of developing pre
eclampsia if the mother has chonic renal failure, twin pregnancy, is over 40
years old, is diabetic or has a family history of pre-eclampsia.
Pre-eclampsia rarely occurs before the 20th
week of pregnancy and is usually associated with hydatidiform mole, with
multiple pregnancy or with foetal triploidy.
Patients who develop pre-eclampsia early in
pregnancy pose problems for foetal viability and tend to exhibit more maternal
features of pre-eclampsia.
Patients with pre-eclampsia may have other
symptoms including hyperreflexia and low platelet count. Up to one third of
patients have thombocytopenia. Severe pre-eclampsia can cause disseminated
intravascular coagulopathy, pulmonary oedema, cardiac failure, renal failure,
hepatic and splenic infarcts, cerebral haemorrhage, convulsions(eclampsia), the
HELLP syndrome (Haemolysis, Elevated Liver enzymes, Low Platelets) and death.
Severe pre-eclampsia is a systolic blood
pressure greater than 160 mmHg, or diastolic blood pressure greater than 110
mmHg or urine output less than 500 ml/24 h, or urine protein greater than 5
g/24 h with or without headache, visual disturbances and epigastric pain.
Management of Pre-eclampsia
The management of pre-eclampsia is to deliver
the baby and treat the symptoms. Mild pre-eclampsia can be treated with oral
anti-hypertensives such as labetolol or alpha methyldopa and bed rest so that
the pregnancy can progress until the foetus is more mature.
Severe pre-eclampsia needs to be treated
definitively with delivery of the baby and placenta. The mother’s condition
must be stabilised so that the anaesthetic can be performed safely. This will
involve controlling the blood pressure, ensuring adequate intravascular
filling, checking that the coagulation is normal, and prevention of eclampsia.
The mother’s blood pressure, urine output, conscious state and tendon reflexes
must be frequently checked. Ideally the anaesthetist would arrange blood tests
for liver function test, full blood count, serum magnesium level and clotting.
Hypertension
Hypertension should be treated with an
intravenous anti-hypertensive such as hydralazine or labetolol. The aim is to
keep the mean arterial pressure between 100 and 140 mmHg. It is important to
maintain placental perfusion. Hydralazine can be given as bolus injections of 5
to 10 mg every 15 minutes or as an infusion of 2 to 4 mg/h.
Fluid Resuscitation
Pre-eclampsia causes a reduced intravascular
volume and the mother will need intravenous fluid replacement. The anaesthetist
must assess the severity of dehydration (is the patient thirsty, is the urine
output less than 30 ml/h, is the tongue dry, is the central venous pressure
low?). Intravenous fluid replacement should be guided by monitoring of the
central venous pressure and urine output (with a urinary catheter). The patient
should have at least 1ml/kg of urine output each hour. The central venous
pressure should be 2 to 4 cmH2O. It is important not to give too
much intravenous fluid as the patient may develop pulmonary oedema due to leaky
capillaries. Most patients will need 1 litre of intravenous fluid rapidly
followed by 1 litre over the next hour. If the urine output is still less than
30 ml/h the patient may need another 500 ml over half an hour until urine
output is normal or the central venous pressure is greater than 4 cmH2O.
If the central venous pressure is greater than 4 cmH2O and the urine
output is still low, then the patient may need a diuretic such as frusemide.
Coagulopathy
Ideally the patient’s coagulation and
platelet concentration should be tested. Pre eclampsia can cause a rapid fall
in platelet count. Spinal and epidural anaesthesia should not be performed if
the platelet count is less than 100,000.
Convulsion control
The anaesthetist must assess the risk of the
patient having a convulsion. Hyper-reflexia, headache, visual changes and high
blood pressure all indicate that the patient may fit. Giving an anti-epileptic
drug such as diazepam or phenytoin may prevent convulsions. Magnesium sulphate
is the best drug. It will cause vasodilatation and also cause central nervous
system depression. Magnesium sulphate is given as an intravenous bolus of 2 to
4 g over 15 minutes, then as an intravenous infusion of 1 to 3 g/h. Ideally
magnesium blood levels should be monitored. An alternative regimen (described
by Lucas, Leveno & Cunningham in 1995) is to give 10 g of magnesium
sulphate intramuscularly followed by 5 g intramuscularly every 4 hours until 24
hours post delivery. The aim is to maintain magnesium levels at 4 to 8 mEq/l (2
to 4 mmol/l). (Deep tendon reflexes diminish at 10 mEq/l or 5 mmol/l and
respiratory paralysis and heart block occur at 15 mEq/l or 7.5 mmol/l. If blood
magnesium levels cannot be monitored then the patient must have frequent
observation of their tendon reflexes, respiratory rate and heart rate. If
depression of reflexes occurs, stop the infusion until the reflexes return).
Magnesium will also increase the patient’s sensitivity to depolarising and
non-depolarising muscle relaxants. The anaesthetist will need to reduce the
dose of muscle relaxants (to 30% of the predicted dose) if the patient needs a
general anaesthetic. Calcium gluconate is the antidote for magnesium sulphate.
Diazepam is still widely used but magnesium
sulphate is the preferred agent.
The anaesthetist may be required to provide
labour analgesia, provide anaesthesia for caesarean section or be involved in
the medical management of the pre-eclamptic patient. They must ensure that
patient has been optimally treated prior to an anaesthetic.
If coagulation is normal, an epidural will
provide good labour analgesia and help control the blood pressure.
Choice of Anaesthetic
The choice of anaesthetic technique for caesarean
section will depend on the health of the mother, health of the foetus and the
technical ability of the anaesthetist. (It is safer to use a familiar
technique). General anaesthesia may avoid the hypotension that can occur with
spinal anaesthesia and is safer with thombocytopenia, but pre-eclamptic
patients may be very difficult to intubate. There may be severe oedema of the
airway. The anaesthetist must assess the pre-eclamptic patient’s airway with
extreme care and always be prepared for a difficult or impossible intubation.
The anaesthetist must also be aware that the pre-eclamptic patient may have
exaggerated cardiovascular responses (hypertension, tachycardia) to intubation
and extubation.
Spinal/epidural anaesthesia should only be
performed if the patient’s coagulation is normal. The platelet count should
ideally be above 100,000. Spinal anaesthesia should not cause a severe drop in
blood pressure if the patient’s blood pressure is controlled and they have had
adequate fluid resuscitation.
Post Delivery Care
The anaesthetist must be aware that the
patient remains at risk from pre-eclampsia for up to 48 hours after delivery.
More than 50% of convulsions and pulmonary complications occur in the post
partum period.
|